Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,902.00

16.45 (0.87%)

, FDX

FedEx

$166.32

2.61 (1.59%)

20:02
06/18/19
06/18
20:02
06/18/19
20:02

Amazon.com expanding next-day delivery with more rented jets, WSJ says

Amazon.com (AMZN) is adding smaller aircraft to its fleet of jet rentals as part of an effort to expand its next-day delivery capacity, The Wall Street Journal's Doug Cameron reports. The move is said to come after the decision by FedEx (FDX) to end its shipping agreement with the company to focus on delivery capabilities of other retailers. Amazon is planning to rent 15 more 737-800 jets from Boeing (BA) that will be converted for cargo shipments. Reference Link

AMZN

Amazon.com

$1,902.00

16.45 (0.87%)

FDX

FedEx

$166.32

2.61 (1.59%)

UPS

UPS

$102.16

0.76 (0.75%)

BA

Boeing

$374.21

19.31 (5.44%)

  • 18

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

AMZN Amazon.com
$1,902.00

16.45 (0.87%)

06/12/19
WEDB
06/12/19
NO CHANGE
Target $100
WEDB
Outperform
GrubHub best positioned amid Amazon Restaurants shutdown, says Wedbush
Wedbush analyst Ygal Arounian notes that Amazon (AMZN) announced that it will shut down Amazon Restaurants in the U.S., which he views as further evidence that rationality is creeping into the U.S. 3P food takeout market. The analyst sees GrubHub (GRUB) as the best positioned to maintain/regain strength in this environment, as it is the only U.S. third-party takeout provider that is profitable and has always been rational in only adding LTV positive customers. Arounian reiterates an Outperform rating and $100 price target on GrubHub's shares, but adds that he sees "significant room" for multiple expansion if investors regain confidence in this sector.
06/12/19
WEDB
06/12/19
NO CHANGE
Target $155
WEDB
Outperform
Microsoft momentum not slowing down, says Wedbush
Wedbush analyst Daniel Ives believes Microsoft (MSFT) remains in an "enviable position" heading into the rest of 2019 and 2020 on the heels of its cloud success and is firing on all cylinders around its Office 365 and Azure strategic vision based on his recent checks. So far in the June quarter the analyst is seeing a "clear acceleration" of larger and more strategic enterprise cloud deals as believes "Redmond is poised to win the lion's share" of the next phase of cloud deployments versus Amazon (AMZN). The shift to cloud is a major secular trend that is significantly benefiting Microsoft in the field and should continue its momentum heading into the next 12-18 months, he contends. Ives reiterates an Outperform rating and $155 price target on Microsoft's shares.
06/12/19
BOFA
06/12/19
NO CHANGE
Target $108
BOFA
Buy
Less competition for GrubHub amid Amazon Restaurants exit, says BofA/Merrill
Amazon's (AMZN) discontinuation of its U.S. restaurant delivery service removes the threat to GrubHub (GRUB) of Amazon expanding its online food delivery business organically, BofA/Merrill analyst Nat Schindler tells investors in a research note. Schindler notes that online food delivery is a large, fragmented, and rapidly evolving market with significant capital infusion from public and private investors, and Amazon may be shifting from "build" to "partner or buy" in this market. The analyst contends that while GrubHub has lost some market share recently, he sees growth as healthy overall, and says the disconnect between rising private valuations and recent declines in GrubHub's market cap may create an opportunity.
06/12/19
KEYB
06/12/19
NO CHANGE
Target $190
KEYB
Overweight
FedEx price target lowered to $190 from $215 at KeyBanc
KeyBanc analyst Todd Fowler lowered his price target for FedEx (FDX) to $190 from $215 ahead of Q4 to reflect trade uncertainty and some impact of the non-renewal of the U.S. domestic Express contract with Amazon (AMZN), partially offset by improved Ground margins, voluntary buyout benefits, and modest Freight contribution. The analyst reiterates an Overweight rating on the shares.
FDX FedEx
$166.32

2.61 (1.59%)

06/11/19
FBCO
06/11/19
NO CHANGE
Target $184
FBCO
Outperform
FedEx price target lowered to $184 from $241 at Credit Suisse
Credit Suisse analyst Allison Landry lowered his price target for FedEx (FDX) to $184 from $241 in light of the deceleration in the U.S. and global macro and temporary volume and cost headwinds, including 7-day Ground and non-renewal of the Amazon (AMZN) Domestic Express contract. The analyst reiterates an Outperform rating on FedEx shares.
06/10/19
BERN
06/10/19
NO CHANGE
BERN
Not the first time FedEx declines to provide service to Amazon, says Bernstein
Bernstein analyst David Vernon notes that FedEx (FDX) announced that it would not be renewing its U.S. Express contract with Amazon (AMZN). The analyst believes the majority of FedEx's revenue with Amazon was tied up in the deferred air network within Express, and the loss of this business could create a $700-750M hole in the day network. On the other hand, FedEx stock is sensitive to Amazon headlines, and removing the volume partially mitigates this risk as it removes the speculation about how much of FedEx's revenue is or is not from Amazon, he contends. Vernon also thinks the failure to reach commercial terms on this contract is as much about what FedEx will accept economically as it is about what Amazon wants to do with its supply chain. This is not the first time that FedEx has declined to provide service to Amazon, as it previously walked away from what Amazon was asking the company to do with the SmartPost in Ground, he adds.
06/18/19
SPHN
06/18/19
NO CHANGE
Target $210
SPHN
Overweight
FedEx recent headlines like 'entering The Twilight Zone,' says Stephens
Stephens analyst Jack Atkins said he understands if FedEx (FDX) investors feel some headline fatigue given it seems like "entering The Twilight Zone" with news of an expansion to its Ground operating week, canceling bonuses, telling Amazon (AMZN) it wasn't interested in its U.S. Express package business and China having launched a probe all just within the last few weeks. While Atkins lowered his Q4 outlook for FedEx to reflect increased concern about global trade trends and deteriorating demand for global airfreight capacity, he also believes the bar is low and notes the stock is trading near trough valuations. Atkins keeps an Overweight rating and $210 price target on FedEx ahead of the company's Q4 report and expected FY20 guidance announcement on June 25.
UPS UPS
$102.16

0.76 (0.75%)

04/01/19
BREN
04/01/19
DOWNGRADE
BREN
Hold
FedEx downgraded to Hold from Buy at Berenberg
Berenberg analyst Joel Spungin downgraded FedEx (FDX) to Hold from Buy. The analyst's in-depth review of European parcel markets suggests FedEx's integration of TNT "has some way to go." Further, the company is exposed to some "lower-growth, more economically sensitive segments of the market than peers," Spungin tells investors in a research note. He believes a slowdown in international markets, "indigestion" from the TNT acquisition and higher costs in Ground mean FedEx's margin improvement "will take longer to come through." The analyst this morning also upgraded UPS (UPS) to Buy from Hold.
04/01/19
04/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Hold at Berenberg with analyst Joel Spungin saying he is increasingly confident that UPS will deliver margin improvement in both its International business and the U.S. this year, following an in-depth review of European parcel markets. 2. AstraZeneca (AZN) upgraded to Outperform from Market Perform at Cowen with analyst Steve Scala saying the 5% stock decline on news of the company's partnership with Daiichi Sankyo for trastuzumab deruxtecan, which he calls a "promising" breast cancer drug, offers a compelling entry point. 3. Energizer (ENR) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Jason English saying he sees a credible path to top-tier EBIT, EBITDA and EPS growth over the next three years "fueled almost entirely" by debt-reduction and synergies from its recently completed deals for the Global Battery & Lighting business and Global Auto Care business of Spectrum Brands (SPB). 4. Anadarko (APC) resumed with a Buy from Neutral at Citi with analyst Robert Morris citing the stock's underperformance over the past three months and the company's recent success in the Delaware Basin for the upgrade. 5. F5 Networks (FFIV) upgraded to Buy from Neutral at Nomura Instinet with analyst Jeffrey Kvaal saying "long an out-of-favor name," F5 shares are now ~25% below their 2018 peak following the acquisition of Nginx. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/19
CHLM
05/22/19
NO CHANGE
Target $6
CHLM
Buy
UPS deal validates Clean Energy as dominant RNG provider, says Craig-Hallum
Craig-Hallum analyst Eric Stine said Clean Energy Fuels' (CLNE) 7-year supply pact with UPS (UPS) provides strong validation of renewable natural gas as a transportation fuel and validates Clean Energy as the "dominant" RNG provider. The move by UPS, which operates the largest for-hire fleet in the U.S., likely serves as a catalyst for increased RNG adoption by other fleets, said Stine, who also sees the deal leading to incremental volumes for Clean along with incremental EBITDA from RIN credits. Stine reiterates a Buy rating and $6 price target on shares of Clean Energy, which are up 7.5% to $2.99 in afternoon trading.
05/30/19
DBAB
05/30/19
NO CHANGE
DBAB
Hold
Deutsche Bank makes 'Catalyst Call Buy' on UPS
Deutsche Bank analyst Amit Mehrotra added shares of UPS (UPS) as a "Catalyst Call Buy," hedged against the Industrial Select Sector SPDR (XLI). The analyst views UPS as defensive at current levels in an environment of heightened China/U.S. trade concerns. This is supported by the company's "healthy" balance sheet, "high" dividend and "manageable" China/trade exposure, Mehrotra tells investors in a research note. He estimates estimate UPS's China sales are just $1.5B on a revenue base of $75. Nonetheless, the analyst's long-term fundamental rating on UPS remains Hold.
BA Boeing
$374.21

19.31 (5.44%)

05/28/19
EVER
05/28/19
DOWNGRADE
Target $60
EVER
In Line
Southwest downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Duane Pfennigwerth downgraded Southwest Airlines (LUV) to In Line from Outperform with a $60 price target, pointing to the negative impact that the grounding of Boeing's (BA) 737 MAX jet has had on the air carrier. In a research note to investors, Pfennigwerth says Southwest's inability to grow is due to its reliance on the 737 MAX, and in return for betting on the MAX as its longer-term growth platform, Southwest has gotten operational "headaches," lost market share and likely short-term impact to its brand when the MAX returns to service. The analyst sees Southwest shares as range bound until the MAX formally returns to service.
05/24/19
MSCO
05/24/19
NO CHANGE
Target $500
MSCO
Overweight
Morgan Stanley keeps Overweight rating on Boeing after 'good enough' FAA meeting
Morgan Stanley analyst Rajeev Lalwani said he views the FAA meeting on May 23 with global regulators on the status of the 737 MAX as supportive of Boeing and "good enough" given that there were no major setbacks in progressing on the return to service of the MAX, there appeared to be a collaborative approach among aviation authorities and a 1-2 month timeline was not ruled out. Lalwani, who thinks the dialogue is shifting more towards when the aircraft can get back into service as opposed to if, said he remains comfortable with his Overweight rating and $500 price target on Boeing shares, especially with the shares down about 20% from their recent highs.
06/11/19
JEFF
06/11/19
NO CHANGE
Target $448
JEFF
Buy
Boeing's May deliveries 'weak' due to 737 MAX grounding, says Jefferies
Boeing delivered 30 commercial aircraft in May vs. 68 a year ago, Jefferies analyst Sheila Kahyaoglu tells investors in a research note, saying that the deliveries were weak given the 737 MAX grounding. The analyst continues to forecast Q2 deliveries of 77 and FY19 deliveries of 665, assuming no 737 MAX deliveries until Q3, and sees the Paris Air Show as a potential pick up in order activity. Kahyaoglu has a Buy rating and $448 price target on Boeing shares.
06/18/19
BOFA
06/18/19
NO CHANGE
Target $420
BOFA
Neutral
Boeing 737 MAX rebranding wouldn't fix issues, says BofA/Merrill
BofA/Merrill analyst Ronald Epstein commented on Day 1 of the Paris Air Show, telling investors that "there were more questions than answers" regarding Boeing's 737 MAX. In a research note to investors, Epstein says his team's conversations with suppliers and other industry participants did not provide additional clarity on the certification of the 737 MAX, and says Boeing appears to be using the show as opportunity to explain what has gone wrong with 737 Max program, adding that he is "surprised" that the 737 MAX is in the position that it is. Epstein also notes that a rebranding effort for the 737 MAX would likely not fix the confidence issues facing the MAX, as "A rose by any other name would smell as sweet."

TODAY'S FREE FLY STORIES

TCEHY

Tencent

$0.00

(0.00%)

, MDLA

Medallia

$37.09

(0.00%)

07:31
07/21/19
07/21
07:31
07/21/19
07:31
On The Fly
Opening Day: Start-up DouYou becomes China's biggest Wall Street IPO of 2019 »

Drugmaker Genmab raised…

TCEHY

Tencent

$0.00

(0.00%)

MDLA

Medallia

$37.09

(0.00%)

MIRM

Mirum Pharmaceuticals

$13.51

0.17 (1.27%)

FULC

Fulcrum Therapeutics

$12.49

-0.99 (-7.34%)

PHR

Phreesia

$24.01

-1.15 (-4.57%)

GMAB

Genmab

$18.06

-0.14 (-0.77%)

AMK

AssetMark Financial

$27.71

0.39 (1.43%)

ORCC

Owl Rock

$15.51

0.11 (0.71%)

DOYU

DouYu

$10.50

-0.51 (-4.63%)

NOVA

Sunnova Energy

$0.00

(0.00%)

CSTL

Castle Biosciences

$0.00

(0.00%)

WSG

Wanda Sports

$0.00

(0.00%)

LVGO

Livongo Health

$0.00

(0.00%)

HCAT

Health Catalyst

$0.00

(0.00%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 24

    Jul

  • 31

    Jul

  • 14

    Aug

  • 09

    Sep

  • 16

    Sep

  • 15

    Oct

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

PYPL

PayPal

$118.65

-1.22 (-1.02%)

, V

Visa

$179.18

-1.34 (-0.74%)

08:31
07/20/19
07/20
08:31
07/20/19
08:31
Periodicals
MasterCard, Visa among best stocks to play fintech boom, Barron's says »

The fintech units within…

PYPL

PayPal

$118.65

-1.22 (-1.02%)

V

Visa

$179.18

-1.34 (-0.74%)

MA

MasterCard

$275.51

-1.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

  • 30

    Jul

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

, SBNY

Signature Bank

$123.87

1.07 (0.87%)

08:28
07/20/19
07/20
08:28
07/20/19
08:28
Periodicals
KeyCorp, U.S. Bancorp better positioned for Fed rate cut, Barron's says »

KeyCorp (KEY), Signature…

USB

U.S. Bancorp

$54.98

-0.2 (-0.36%)

SBNY

Signature Bank

$123.87

1.07 (0.87%)

KEY

KeyCorp

$17.45

0.15 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

  • 16

    Oct

CMG

Chipotle

$746.80

-17.43 (-2.28%)

08:24
07/20/19
07/20
08:24
07/20/19
08:24
Periodicals
Chipotle stock made 'stunning' comeback, Barron's says »

Chipotle's stock is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Sep

BYND

Beyond Meat

$176.65

6.28 (3.69%)

07:40
07/20/19
07/20
07:40
07/20/19
07:40
Periodicals
Beyond Meat could spike after earnings, Barron's says »

After rising so…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

NFLX

Netflix

$315.10

-10.04 (-3.09%)

07:37
07/20/19
07/20
07:37
07/20/19
07:37
Periodicals
Netflix's problems have only just begun, Barron's says »

Netflix has a problem and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, TGT

Target

$88.02

-0.48 (-0.54%)

07:34
07/20/19
07/20
07:34
07/20/19
07:34
Periodicals
Time to aim higher on Target's stock, Barron's says »

As retailers have…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

TGT

Target

$88.02

-0.48 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 21

    Aug

  • 19

    Sep

  • 25

    Sep

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, FDX

FedEx

$167.08

1.69 (1.02%)

07:31
07/20/19
07/20
07:31
07/20/19
07:31
Periodicals
FedEx ups game amid e-commerce growth, Barron's says »

It is time to embrace…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

FDX

FedEx

$167.08

1.69 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 17

    Sep

  • 13

    Nov

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

, MSFT

Microsoft

$136.62

0.33 (0.24%)

07:27
07/20/19
07/20
07:27
07/20/19
07:27
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,964.78

-13.57 (-0.69%)

MSFT

Microsoft

$136.62

0.33 (0.24%)

ORCL

Oracle

$57.55

-0.58 (-1.00%)

AZN

AstraZeneca

$40.11

-0.61 (-1.50%)

BMY

Bristol-Myers

$43.32

-0.72 (-1.63%)

LLY

Eli Lilly

$106.75

-1.57 (-1.45%)

GSK

GlaxoSmithKline

$40.97

-0.44 (-1.06%)

JNJ

Johnson & Johnson

$130.41

-1.62 (-1.23%)

MRK

Merck

$81.39

-1.28 (-1.55%)

NVS

Novartis

$93.58

-0.715 (-0.76%)

PFE

Pfizer

$42.78

-0.28 (-0.65%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$41.94

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 30

    Jul

  • 30

    Jul

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 27

    Aug

  • 28

    Aug

  • 02

    Sep

  • 09

    Sep

  • 16

    Sep

  • 16

    Sep

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 02

    Oct

  • 15

    Oct

  • 04

    Nov

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

18:12
07/19/19
07/19
18:12
07/19/19
18:12
Hot Stocks
Biohaven receives CRL from FDA for application seeking NURTEC approval »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

CE

Celanese

$107.01

0.9 (0.85%)

18:01
07/19/19
07/19
18:01
07/19/19
18:01
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

F

Ford

$10.20

-0.06 (-0.58%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Periodicals
Ford plans to lay off 185 employees at Ontario plant, Reuters reports »

A union local said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 23

    Oct

RTN

Raytheon

$178.55

2.45 (1.39%)

17:48
07/19/19
07/19
17:48
07/19/19
17:48
Hot Stocks
Raytheon awarded $191.01M Air Force contract modification »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UTX

United Technologies

$132.37

1.08 (0.82%)

17:44
07/19/19
07/19
17:44
07/19/19
17:44
Hot Stocks
United Technologies awarded $253.71M Air Force contract »

United Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LMT

Lockheed Martin

$356.90

0.675 (0.19%)

17:40
07/19/19
07/19
17:40
07/19/19
17:40
Hot Stocks
Lockheed Martin awarded $1.47B Missile Defense Agency contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ARES

Ares Management

$28.13

-0.305 (-1.07%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Syndicate
Breaking Syndicate news story on Ares Management »

Ares Management files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

HAFC

Hanmi Financial

$21.68

-0.105 (-0.48%)

17:33
07/19/19
07/19
17:33
07/19/19
17:33
Hot Stocks
Hanmi Financial to delay release of Q2 results »

Hanmi Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PAYS

Paysign

$17.49

-0.48 (-2.67%)

17:32
07/19/19
07/19
17:32
07/19/19
17:32
Syndicate
Breaking Syndicate news story on Paysign »

Paysign files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$43.19

0.83 (1.96%)

17:28
07/19/19
07/19
17:28
07/19/19
17:28
Hot Stocks
Methanex reaches final investment decision on methanol plant in Geismar, LA »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

17:17
07/19/19
07/19
17:17
07/19/19
17:17
Conference/Events
Credit Suisse biotech analysts to hold an analyst/industry conference call »

Biotech Analysts provide…

17:14
07/19/19
07/19
17:14
07/19/19
17:14
Conference/Events
UBS retail/hardlines analyst to hold an analyst/industry conference call »

Retail/Hardlines Analyst…

SHIP

Seanergy Marine

$0.64

-0.0425 (-6.25%)

17:05
07/19/19
07/19
17:05
07/19/19
17:05
Hot Stocks
Seanergy Maritime receives noncompliance notice from Nasdaq »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONM

Sonim

$13.42

0.24 (1.82%)

16:41
07/19/19
07/19
16:41
07/19/19
16:41
Conference/Events
Sonim management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

KINS

Kingstone Companies

$8.81

0.09 (1.03%)

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Hot Stocks
Kingstone names Barry Goldstein CEO »

Kingstone Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

16:30
07/19/19
07/19
16:30
07/19/19
16:30
Options
Preliminary option volume of 22.6M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.